CompanyHealthHardware
Curi Bio
Curi Bio is a Seattle biotechnology company building human-relevant preclinical platforms for drug discovery. By combining human iPSC-derived cells, 3D engineered tissues, lab instruments, and AI/ML data analysis, it gives biopharma teams functional human data earlier in development - aiming to bridge the gap between animal/2D-cell models and the clinic across cardiac, skeletal muscle, metabolic, and neuromuscular diseases.
2015Founded
SeattleHQ
$32,300,000 (cumulative across rounds)Total raised to date
biotechnologydrug discoveryipscstem cell biology3d tissue modelspreclinical
